English
Italiano
Deutsch
日本語
中文
Español
For more than 70 years, we have been committed to providing integrated solutions for pharma and healthcare, leveraging on constant investment and the acquisition of skills in new technologies. A rich, international heritage has brought us to become a global player in the pharma industry.
Stevanato Group’s history has its roots in the foundation of Soffieria Stella in Zelarino, near Venice, which specialized in the production of glass bottles. In 1959, the glassware factory moved to Piombino Dese and closed a few years later.
Ompi, the specialist in glass primary packaging, was born in its current location in Piombino Dese, Padua. A few years later, leveraging on its in-house technological competencies brought in by Spami, which is dedicated to the production of glass converting lines, the company will develop a unique expertise in the production of high-quality glass primary packaging.
Spami is established in Piombino Dese. It is a company specializing in the design and production of high-speed, high-precision glass forming lines to obtain high-quality containers from tubing.
Stevanato Group acquires a manufacturing plant for glass containers in Latina, Italy.
Medical Glass, a glass container manufacturing plant based in Slovakia, joins Stevanato Group and marks the first step of the internationalization process.
Start-up of the manufacturing of sterilized glass containers: EZ-fill®
A new department dedicated to the production of EZ-fill® ready-to-fill, sterilized syringes opens in Piombino Dese. It is soon followed by the opening of dedicated production departments for ready-to-use vials and cartridges.
The Group acquires Optrel, an Italian company specialized in the manufacture of inspection machines for glass containers for pharmaceutical industry.
Stevanato Group opens its first greenfield site in Monterrey, Mexico.
A new commercial office opened in China in 2012, and a new plant manufacturing glass containers in Zhangjiagang was inaugurated a few years later.
Stevanato Group acquires InnoScan, a Danish company who specializes in the production of high-speed inspection systems for complex drugs.
The Group started up its internal laboratory dedicated to performing analytical services and studying the interactions of drugs and containers.
The Danish company SVM, which specializes in the assembly and packaging equipment of medical devices, was acquired.
Stevanato Group acquires Balda, a company with manufacturing facilities in Germany and California, specializing in plastic development and manufacturing for diagnostic consumables, drug delivery systems, and medical components.
A new glass container manufacturing plant, the third greenfield project of the Group, is opened in Sete Lagoas, Brazil.
A commercial office to be closer to the local customers has been opened in Nagoya, Japan.
The Group expanded its premises in Piombino Dese, with a new production plant on an area of 17,000 sq meters for the manufacturing of syringes.
US TEC Opening
US Technology Excellence Center opens in Boston, Massachusetts to provide Biopharma companies with integrated analytical services and effective project management for drug development and commercialization.
The listing represents a significant milestone for Stevanato Group, enabling the company to further strengthen its integrated offerings, expand market penetration across all business segments, and accelerate growth.
EMEA Technology Excellence Center expansion at HQ in Piombino Dese to provide Biopharma companies integrated analytical services to de-risk and accelerate drug product development and commercialization.
The new facilities are expanding the production capacity of Drug Containment Solutions and Delivery Systems, with the aim of meeting the modern challenges of the European and North American markets, while enhancing service to pharmaceutical customers.